Search the Newsreel

Mirum Pharmaceuticals(MIRM.US) Officer Sells US$4 Million in Common Stock

A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.

We're Keeping An Eye On Titan Minerals' (ASX:TTM) Cash Burn Rate

Imperial Metals (TSX:III) Shares Climbed, What Is Driving Attention Today?

Daily Special: Etherstack, Genesis Resources, Pivotal Metals, Latitude 66, Many Peaks Minerals

What Does FLSmidth (CPSE:FLS) Gain From Its New Service Business Chief?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. FLSmidth (CPSE:FLS) has appointed Petri Virrankoski as President of its Service Business Line. Virrankoski brings experience in turnaround, growth, profitability and operational improvement …

Arrow Minerals Strikes Pilbara Joint Venture with Leeuwin Metals

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock

Amylyx Pharmaceuticals has announced the pricing of an upsized underwritten public offering of 14,090,000 shares of its common stock at $35.50 per share, aiming to raise $500.2 million before deductions. The company plans to use the net proceeds for pre-commercial activities for avexitide, research …

Form 144(Amend) | Aura Minerals(AUGO.US) Insider Proposes to Sell 4.68 Million in Common Stocks

An insider at Aura Minerals (AUGO.US) has proposed to sell 4.68 million common stocks, as indicated by a Form 144(Amend) filing. This type of filing suggests a planned sale of restricted or control securities. The proposed sale involves a significant number of shares, which …

Air Products And Chemicals (APD) Draws Fresh Analyst Interest, Is An 11% Discount Warranted?

Air Products and Chemicals (APD) is attracting renewed analyst interest due to strong recent earnings, despite ongoing concerns about high capital spending, project exit charges, and helium pricing. The stock is currently trading at an 11.4% discount to analyst targets and estimated intrinsic value, …

Why Eton Pharmaceuticals Is Top of the Class Today

Raptor Metals Maps Out Intensive 2026 Copper Exploration Push in Canada and Australia

EXL (EXLS) Stock Looks Above Fair Value Despite Fair Earnings

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. ExlService Holdings has delivered a 54.3% gain over the past 5 years, yet its current checks suggest the stock is not a clear bargain and …

Telix Pharmaceuticals (ASX:TLX) Shares Rise Today as H1 Revenue Climbs 22% to US$477 Million

Telix Pharmaceuticals (ASX:TLX) saw its shares rise as it reported a 22% increase in H1 2026 revenue to US$477 million, with a gross margin of 55%. Adjusted EBITDA surged by 146% to US$52 million, and the company achieved a profit after tax of US$38 …

Is MP Materials (MP) Too Expensive After Its Sales Surge?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. MP Materials stock has delivered a very strong 177.7% gain over the past three years, yet the current valuation checks lean more cautious, with the …

Telix Pharmaceuticals delivers robust half-year earnings and pipeline progress

Telix Pharmaceuticals (ASX: TLX) reported robust half-year results, with revenue up 22% to US$477 million and adjusted EBITDA surging 146% to US$52 million. The company made significant progress in pipeline development, strategic collaborations, and global manufacturing expansion. Telix reaffirmed its FY26 revenue guidance of …

Lodestar Minerals (ASX:LSR) Adds Chile Copper Project as Pacifico Acquisition Expands Exploration Portfolio

What's Going On With Eupraxia Pharmaceuticals Inc Stock Wednesday?

Regeneron (REGN) Results Review: Profit Per Share Clears Its Benchmark in the Current Update; Closing Reaction

Why Park Hotels & Resorts (PK) Is Up 6.6% After Returning To Profitability In Q2 2026

Park Hotels & Resorts (PK) has returned to profitability in Q2 2026, reporting US$47 million in net income and positive EPS, a significant improvement from previous losses. Despite largely flat revenue, the company's focus on margin execution and shareholder returns, alongside a reiterated dividend …

Altitude Minerals halts Byrock drilling after weak assays, shifts focus to Nevada’s Firenze project

Augustus Minerals Targets High-Grade Veins in Next Music Well Drilling Phase

Beacon Minerals Surges as New Gold Study Stuns Market

PMV (PMVP) Latest Quarter: The Available Earnings Metric Delivers a Beat in the Latest Reading; Closing Move: The Stock Records a 3.23% Increase on the Day - Analyst Coverage Count

Aura Minerals (AUGO) fund lines up BDR sale worth 216,028.90

Kapitalo K10 Previdencia Master Fundo de Investimento Multimercado intends to sell up to 7,769 Brazilian depositary receipts (BDRs) of Aura Minerals Inc. (AUGO) on B3 by August 19, 2026, with an estimated aggregate market value of 216,028.90. These BDRs represent common shares acquired in …

Mirum Pharmaceuticals (MIRM) SVP exercises 40k options, sells shares

Jolanda Howe, SVP, Global Controller at Mirum Pharmaceuticals (MIRM), exercised 40,000 employee stock options at $6.27 per share and subsequently sold all 40,000 common shares at $100.00 per share on August 18, 2026. This transaction resulted in an approximate pre-tax spread of $3.75 million. …

Corvus (CRVS) Q2 2026 Results: The EPS Result Is Below Expectation; Market Response: The Stock Records a 3.84% Increase in the Current Update - Financial Health Score

Litchfield Minerals Secures Harts Range Licence to Advance Sybil Copper Target

Aurinia Pharmaceuticals (AUPH) Stock Still Looks Cheap After A 74% Gain

Dorchester Minerals CFO Leslie Moriyama Acquires 5,197 Common Units on August 19, 2026

Dorchester Minerals CFO Leslie A. Moriyama acquired 5,197 common units of the company on August 19, 2026, as disclosed in a Form 4 filing. This transaction increased her beneficial ownership to a total of 103,405 common units. The units were purchased at $28.3 each …

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance1: Double-digit revenue growth and gross …

Titan Minerals (ASX:TTM) Cash Burn Puts Funding Outlook in Focus

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Major Shareholder Group Walters Buys 4,335,000 Shares of Stock

Major shareholder Group Walters purchased 4,335,000 shares of Zentalis Pharmaceuticals (NASDAQ:ZNTL) stock for $15.17 million, increasing their position by 32.09% to 17.84 million shares. This transaction occurred on August 14th, with the stock bought at an average price of $3.50 per share. Despite the …

Wyndham Hotels CEO Geoffrey Ballotti Executes Stock Options and Sells Shares Under 10b5-1 Plan in August 2026

Geoffrey A. Ballotti, President and CEO of Wyndham Hotels & Resorts, Inc. (NYSE:WH), exercised 20,429 non-qualified stock options at $65.21 per share and concurrently sold 19,414 shares of common stock at a weighted average price of $72.7092 on August 17, 2026. These transactions were …

Aura Minerals (NASDAQ: AUGO) fund lines up multi-million NASDAQ share sale

A fund affiliated with Aura Minerals, Kapitalo International Fund SPC - Segregated Portfolio A, plans to sell 203,023 common shares of Aura Minerals (AUGO) on NASDAQ, valued at approximately $16.6 million, through a Rule 144 filing. This notice indicates a significant planned divestment by …

Aura Minerals (AUGO) holder plans 370 BDR sale on B3

A holder of Aura Minerals (AUGO), Kapitalo Mercante Master Fundo de Investimento Multimercado, has notified its intention to sell 370 Brazilian Depositary Receipts (BDRs) on the B3 exchange. The BDRs, with an aggregate market value of 10,288.41, were acquired in open market purchases in …

Jolanda Howe Sells 40,000 Shares of Mirum Pharmaceuticals (NASDAQ:MIRM) Stock

Jolanda Howe, SVP of Mirum Pharmaceuticals (NASDAQ:MIRM), sold 40,000 shares of the company's stock for $4 million on August 18th, reducing her stake by 96.91% to 1,274 shares. This sale follows several other transactions since June. The company's stock trades at $102.24 with a …